Burul Makenbayeva: The government doesn’t know how Kyrgyzstan’s accession to CU to affect market drugs and health care system
\"The government doesn\'t know how Kyrgyzstan\'s accession to the CU will affect market drugs and health care system,\" the coordinator of the Coalition NGO for the transparency of drug supply Burul Makenbayeva said today at a press conference.
According to her, without waiting for a response from the Ministry of Economy, the government and parliament, civil society has begun to self-analysis and the search for answers to these questions.
Expert on evidence-based medicine Bermet Barktabasova added that there are enough positive things when entering the union, but there are some risks. At present, the Russian health care itself has faced many challenges, and it has more problems than the KR. \"Our standards - it is a safe treatment, and we have the best conditions for patients. We need to keep the bar that exists at the moment,\" the expert on evidence-based medicine Bermet Barktabasova added.